Mirum Pharmaceuticals, Inc. - common stock (MIRM): Price and Financial Metrics
MIRM Price/Volume Stats
| Current price | $41.51 | 52-week high | $48.89 |
| Prev. close | $41.13 | 52-week low | $23.14 |
| Day low | $40.58 | Volume | 1,185,000 |
| Day high | $42.85 | Avg. volume | 546,432 |
| 50-day MA | $42.05 | Dividend yield | N/A |
| 200-day MA | $35.10 | Market Cap | 1.99B |
MIRM Stock Price Chart Interactive Chart >
Mirum Pharmaceuticals, Inc. - common stock (MIRM) Company Bio
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz on May 7, 2018 and is headquartered in Foster City, CA.
MIRM Price Returns
| 1-mo | -4.53% |
| 3-mo | 6.55% |
| 6-mo | 19.11% |
| 1-year | 38.37% |
| 3-year | 164.90% |
| 5-year | 74.27% |
| YTD | 40.62% |
| 2023 | 51.38% |
| 2022 | 22.26% |
| 2021 | -8.65% |
| 2020 | -28.79% |
| 2019 | N/A |
Loading social stream, please wait...